Trial intelligence / Profile preview

Dexmedetomidine versus fentanyl PCA after abdominal cancer surgery

ChiCTR-TRC-14004896Phase 4Recruiting

Sponsor
Shandong Cancer Hospital
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine in abdominal malignancy (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoints: Visual analog score, FOXP3 and 3 more. Started Jul 2014; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

abdominal malignancy

Beyond the preview

Go deeper on ChiCTR-TRC-14004896.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004896.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call